Contribution of the baroreflex afferent nerves to the production of vasoconstricted hypertension in volume-expanded dogs.
Dextran in lactated Ringer's solution (20 ml/kg) was infused for 1 hour into anesthetized dogs with sinoaortic denervation and vagotomy (deafferentation; n = 10) and dogs treated with hexamethonium (de-efferentation; n = 13) to compare with our previous observation in dogs with an intact autonomic nervous system (control, n = 34). During the infusion, increase in blood pressure associated with increase in cardiac output was observed in all three groups. The increases in blood pressure were larger in the two groups with an impaired autonomic nervous system. In the recovery period, the control dogs and the hexamethonium-treated dogs showed gradual increases in total peripheral resistance and in vasoconstricted hypertension 3 hours after stopping the infusion. In contrast, the dogs with sinoaortic denervation and vagotomy did not show any increase in total peripheral resistance. The vasoconstricted groups showed peaks of natriuresis soon after the infusion, not 3 hours after the infusion when vasoconstriction was observed, although the dogs with deafferentation did not show a significant increase in natriuresis. Norepinephrine (0.5 micrograms/kg) was administered intravenously before and after volume expansion, and the pressor responses in the three groups after volume expansion were enhanced similarly (143%, 128%, and 136%, respectively). These results indicate that the afferent signals from peripheral vessels to the brain contribute to the production of vasoconstricted hypertension after acute volume expansion and that the vasoconstriction is independent of pressor hypersensitivity and is dissociated in time from the natriuresis.
Otsuka
A
A
Department of Geriatric Medicine, Osaka University Medical School, Japan.
Ogihara
T
T
Mikami
H
H
Kohara
K
K
Katahira
K
K
Tsunetoshi
T
T
Kumahara
Y
Y
D000344:Afferent Pathways; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume; D004231:Diuresis; D004285:Dogs; D006439:Hemodynamics; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology*; D009318:Natriuresis; D009638:Norepinephrine / Q000494:pharmacology; D011311:Pressoreceptors / Q000502:physiology*; D012018:Reflex / Q000502:physiology; D014630:Vagus Nerve / Q000502:physiology*; D014661:Vasoconstriction
D006584:Hexamethonium Compounds; D018738:Hexamethonium; D009638:Norepinephrine